157 related articles for article (PubMed ID: 23042022)
1. Interferon-α for unresectable progressive and symptomatic plexiform neurofibromas.
Kebudi R; Cakir FB; Gorgun O
J Pediatr Hematol Oncol; 2013 Apr; 35(3):e115-7. PubMed ID: 23042022
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas.
Jakacki RI; Dombi E; Steinberg SM; Goldman S; Kieran MW; Ullrich NJ; Pollack IF; Goodwin A; Manley PE; Fangusaro J; Allen R; Widemann BC
Neuro Oncol; 2017 Feb; 19(2):289-297. PubMed ID: 27510726
[TBL] [Abstract][Full Text] [Related]
3. Management of plexiform neurofibroma with interferon alpha.
Citak EC; Oguz A; Karadeniz C; Okur A; Memis L; Boyunaga O
Pediatr Hematol Oncol; 2008 Sep; 25(7):673-8. PubMed ID: 18850480
[TBL] [Abstract][Full Text] [Related]
4. Clinic-based study of plexiform neurofibromas in neurofibromatosis 1.
Waggoner DJ; Towbin J; Gottesman G; Gutmann DH
Am J Med Genet; 2000 May; 92(2):132-5. PubMed ID: 10797438
[TBL] [Abstract][Full Text] [Related]
5. Response of NF1-related plexiform neurofibroma to high-dose carboplatin.
Hummel T; Anyane-Yeboa A; Mo J; Towbin A; Weiss B
Pediatr Blood Cancer; 2011 Mar; 56(3):488-90. PubMed ID: 21225936
[TBL] [Abstract][Full Text] [Related]
6. Selumetinib in Children with Inoperable Plexiform Neurofibromas.
Gross AM; Wolters PL; Dombi E; Baldwin A; Whitcomb P; Fisher MJ; Weiss B; Kim A; Bornhorst M; Shah AC; Martin S; Roderick MC; Pichard DC; Carbonell A; Paul SM; Therrien J; Kapustina O; Heisey K; Clapp DW; Zhang C; Peer CJ; Figg WD; Smith M; Glod J; Blakeley JO; Steinberg SM; Venzon DJ; Doyle LA; Widemann BC
N Engl J Med; 2020 Apr; 382(15):1430-1442. PubMed ID: 32187457
[TBL] [Abstract][Full Text] [Related]
7. Resection of plexiform neurofibromas in children with neurofibromatosis type 1.
Canavese F; Krajbich JI
J Pediatr Orthop; 2011; 31(3):303-11. PubMed ID: 21415691
[TBL] [Abstract][Full Text] [Related]
8. [Exclusive nodular plexiform neurofibroma. An unusual case of neurofibromatosis type 1].
Benchikhi H; Zeller J; Wolkenstein P; Wechsler J; Vidaud D; Revuz J
Ann Dermatol Venereol; 1995; 122(9):601-3. PubMed ID: 8745684
[TBL] [Abstract][Full Text] [Related]
9. Plexiform neurofibromas in NF1: toward biologic-based therapy.
Packer RJ; Gutmann DH; Rubenstein A; Viskochil D; Zimmerman RA; Vezina G; Small J; Korf B
Neurology; 2002 May; 58(10):1461-70. PubMed ID: 12041525
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.
Widemann BC; Babovic-Vuksanovic D; Dombi E; Wolters PL; Goldman S; Martin S; Goodwin A; Goodspeed W; Kieran MW; Cohen B; Blaney SM; King A; Solomon J; Patronas N; Balis FM; Fox E; Steinberg SM; Packer RJ
Pediatr Blood Cancer; 2014 Sep; 61(9):1598-602. PubMed ID: 24753394
[TBL] [Abstract][Full Text] [Related]
11. Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.
Dombi E; Baldwin A; Marcus LJ; Fisher MJ; Weiss B; Kim A; Whitcomb P; Martin S; Aschbacher-Smith LE; Rizvi TA; Wu J; Ershler R; Wolters P; Therrien J; Glod J; Belasco JB; Schorry E; Brofferio A; Starosta AJ; Gillespie A; Doyle AL; Ratner N; Widemann BC
N Engl J Med; 2016 Dec; 375(26):2550-2560. PubMed ID: 28029918
[TBL] [Abstract][Full Text] [Related]
12. Neurofibromatosis type 1 with external genitalia involvement presentation of 4 patients.
Pascual-Castroviejo I; Lopez-Pereira P; Savasta S; Lopez-Gutierrez JC; Lago CM; Cisternino M
J Pediatr Surg; 2008 Nov; 43(11):1998-2003. PubMed ID: 18970931
[TBL] [Abstract][Full Text] [Related]
13. Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromas.
Babovic-Vuksanovic D; Widemann BC; Dombi E; Gillespie A; Wolters PL; Toledo-Tamula MA; O'Neill BP; Fox E; MacDonald T; Beck H; Packer RJ
Pediatr Neurol; 2007 May; 36(5):293-300. PubMed ID: 17509460
[TBL] [Abstract][Full Text] [Related]
14. [Cutaneous manifestations of type 1 neurofibromatosis and their treatment].
Lantiéri L; Wolkenstein P
Ann Chir Plast Esthet; 1998 Aug; 43(4):445-54. PubMed ID: 9926476
[TBL] [Abstract][Full Text] [Related]
15. Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience.
Espírito Santo V; Passos J; Nzwalo H; Carvalho I; Santos F; Martins C; Salgado L; Silva CE; Vinhais S; Vilares M; Salgado D; Nunes S
J Neurooncol; 2020 Apr; 147(2):459-463. PubMed ID: 32108293
[TBL] [Abstract][Full Text] [Related]
16. Is a plexiform neurofibroma pathognomonic of neurofibromatosis type I?
Lin V; Daniel S; Forte V
Laryngoscope; 2004 Aug; 114(8):1410-4. PubMed ID: 15280718
[TBL] [Abstract][Full Text] [Related]
17. Superficial neurofibroma: a lesion with unique MRI characteristics in patients with neurofibromatosis type 1.
Lim R; Jaramillo D; Poussaint TY; Chang Y; Korf B
AJR Am J Roentgenol; 2005 Mar; 184(3):962-8. PubMed ID: 15728625
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas.
Kim A; Gillespie A; Dombi E; Goodwin A; Goodspeed W; Fox E; Balis FM; Widemann BC
Neurology; 2009 Oct; 73(16):1273-9. PubMed ID: 19841379
[TBL] [Abstract][Full Text] [Related]
19. Plexiform neurofibromas in children with neurofibromatosis type 1: frequency and associated clinical deficits.
Nguyen R; Kluwe L; Fuensterer C; Kentsch M; Friedrich RE; Mautner VF
J Pediatr; 2011 Oct; 159(4):652-5.e2. PubMed ID: 21621223
[TBL] [Abstract][Full Text] [Related]
20. Phase I trial of pegylated interferon-alpha-2b in young patients with plexiform neurofibromas.
Jakacki RI; Dombi E; Potter DM; Goldman S; Allen JC; Pollack IF; Widemann BC
Neurology; 2011 Jan; 76(3):265-72. PubMed ID: 21242495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
